Litcius/Paper detail

Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study

Michael E Wechsler, Andrew Menzies-Gow, Christopher E Brightling, Piotr Kuna, Stephanie Korn, Tobias Welte, Janet M Griffiths, Kinga Sałapa, Åsa Hellqvist, Gun Almqvist, Harbans Lal, Primal Kaur, Tor Skärby, Gene Colice, Victor H Cambursano, Marcelo J Fernandez, Fernando D Scherbovsky, Anahi Yanez, Alberto J Tolcachier, Ana M Stok, Fernando J B Verra, Stephanie Korn, Karin Forster, Mathias Rolke, Andrea Ludwig-Sengpiel, Tibor Schmoller, Olaf Schmidt, Katrin Milger-Kneidinger, Martin Hoffmann, Hilke Temme, Anneliese Linnhoff, Tobias Welte, Joachim Kirschner, Piotr Kuna, Barbara Rewerska, Ewa Pisarczyk-Bogacka, Sang Haak Lee, Byung Jae Lee, Heung-Woo Park, Jung-Won Park, Sook Young Lee, You Sook Cho, Kwan Ho Lee, Sevim Bavbek, Bilun Gemicioglu, Dane Ediger, Ilkay Koca Kalkan, Ismail Hanta, Arzu Yorgancioglu, Yevgeniya DytyatkovsKa, Yuriy M Mostovoy, Kyrylo Lebed, Oleh Yakovenko, David I Bernstein, Jeffrey P Tillinghast, Loretta Que, Jan Madison, Todd Rambasek, Kartik Shenoy, Charles A Thompson, Christopher M Chappel, Golda Hudes, Ehab Sorial, Shahrukh A Kureishy, Syed M Rehman, Njira Lugogo, Erika G Gonzalez, Fred C Umeh, Eric J Boren, Jason Sigmon, Hummayun Ismail, Arjun Mohan, Sandeep Bansal, Thomas D Kaelin

2022The Lancet Respiratory Medicine139 citationsDOI

Topics & Concepts

MedicineAsthmaInternal medicinePhase (matter)MEDLINEOral healthPhases of clinical researchOral administrationRespiratory diseaseBronchodilator AgentsDermatology and Skin DiseasesAsthma and respiratory diseasesAllergic Rhinitis and Sensitization
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study | Litcius